Catalyst Wire Dossier Catalyst Wire Dossier

T-1101 tosylate

T-1101 tosylate · Taivex Therapeutics Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T-1101 tosylate, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability Study for T-1101 (Tosylate) Capsules to Treat Advanced Refractory Solid Tumors [Phase 1]

See pricing